Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Colorectal Neoplasms

  Free Subscription


8 Am J Surg
1 Ann Oncol
4 Ann Surg
2 Ann Surg Oncol
2 BMC Cancer
2 Br J Cancer
1 Br J Surg
9 Dis Colon Rectum
2 Eur J Cancer
1 Gastroenterology
1 Int J Cancer
4 Int J Colorectal Dis
4 J Am Coll Surg
6 J Surg Oncol
1 Oncogene
1 Oncol Rep
1 PLoS Comput Biol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

    Is winning the only thing? - Examining the "win ratio" concept in synchronous colorectal liver metastasis.
    Am J Surg. 2023;225:460.

  2. TONELLI CM, Kulshrestha S, Singer M, Pawlik TM, et al
    Use of a national registry to define a composite quality metric for rectal cancer.
    Am J Surg. 2023;225:514-518.
    PubMed         Abstract available

    Trends and benefits of prophylactic ureter catheters in the era of minimally invasive surgery.
    Am J Surg. 2023;225:577-582.
    PubMed         Abstract available

  4. YILMAZ S, Ozgur I, Feinberg A, Catalano B, et al
    Advanced endoscopic resections in the treatment of malignant colorectal lesions: Are early oncological outcomes impacted?
    Am J Surg. 2023;225:537-540.
    PubMed         Abstract available

  5. ENDO Y, Alaimo L, Araujo Lima H, Tsilimigras DI, et al
    Simultaneous versus staged resection for synchronous colorectal liver metastases: The win ratio approach.
    Am J Surg. 2023;225:461-465.
    PubMed         Abstract available

  6. OZGUR I, Liska D, Valente MA, Smith N, et al
    Best surgical approach for splenic flexure colon cancers: Extended versus segmental resection?
    Am J Surg. 2023;225:454-459.
    PubMed         Abstract available

    The optimal extent of colectomy for splenic flexure carcinoma - Extended vs segmental? Less is best!
    Am J Surg. 2023;225:452-453.

  8. TURNER KM, Delman AM, Wima K, Quillin RC, et al
    Microsatellite instability is associated with worse overall survival in resectable colorectal liver metastases.
    Am J Surg. 2023;225:322-327.
    PubMed         Abstract available

    Ann Oncol

  9. ROS J, Matito J, Villacampa G, Comas R, et al
    Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
    Ann Oncol. 2023 Mar 13:S0923-7534(23)00112-6. doi: 10.1016/j.annonc.2023.
    PubMed         Abstract available

    Ann Surg

  10. LOPEZ NE, Nguyen NH, Hull TL, Peters WR, et al
    Gender Related Differences in Surgeon Compensation: Survey Results from the American Society of Colon and Rectal Surgeons.
    Ann Surg. 2023;277:e832-e838.
    PubMed         Abstract available

  11. WANG L, Zhang XY, Zhao YM, Li SJ, et al
    Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).
    Ann Surg. 2023;277:647-654.
    PubMed         Abstract available

  12. KNEIST W, Ghadimi M, Runkel N, Moesta T, et al
    Pelvic Intraoperative Neuromonitoring Prevents Dysfunction in Patients With Rectal Cancer: Results From a Multicenter, Randomized, Controlled Clinical Trial of a NEUROmonitoring System (NEUROS).
    Ann Surg. 2023;277:e737-e744.
    PubMed         Abstract available

  13. MEI WJ, Wang XZ, Li YF, Sun YM, et al
    Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
    Ann Surg. 2023;277:557-564.
    PubMed         Abstract available

    Ann Surg Oncol

  14. VALLEJOS PA, Gonda A, Yu J, Sullivan BG, et al
    ASO Visual Abstract: Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.
    Ann Surg Oncol. 2023 Mar 16. doi: 10.1245/s10434-023-13303.

  15. KEPENEKIAN V, Kefleyesus A, Passot G, Rousset P, et al
    ASO Author Reflections: Colorectal Cancer Patients with Peritoneal Metastases and Other Metastatic Sites Can Benefit from Radical Multifocal Treatment After Comprehensive Evaluation for Accurate Selection.
    Ann Surg Oncol. 2023 Mar 12. doi: 10.1245/s10434-023-13320.

    BMC Cancer

  16. BOGNER A, Weitz J, Piontek D
    The influence of socioeconomic aspects and hospital case volume on survival in colorectal cancer in Saxony, Germany.
    BMC Cancer. 2023;23:228.
    PubMed         Abstract available

  17. HUANG X, Zheng Z, Zeng B, Xiao H, et al
    Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.
    BMC Cancer. 2023;23:238.
    PubMed         Abstract available

    Br J Cancer

  18. ISHINO T, Kawashima S, Tanji E, Ueno T, et al
    Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens.
    Br J Cancer. 2023;128:1166-1175.
    PubMed         Abstract available

  19. KOSUMI K, Baba Y, Yamamura K, Nomoto D, et al
    Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.
    Br J Cancer. 2023;128:1155-1165.
    PubMed         Abstract available

    Br J Surg

  20. CASHIN PH, Soderstrom M, Blom K, Artursson S, et al
    Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.
    Br J Surg. 2023 Mar 15:znad066. doi: 10.1093.

    Dis Colon Rectum

  21. FANG C, Yu Y, Wang C
    Did Compliance of Adjuvant Therapy Impact the Oncologic Outcome of Patients With Rectal Cancer Having Anastomotic Leakage?
    Dis Colon Rectum. 2023;66:e176.

  22. CHAPMAN BC, Lai SH, Friedrich T, Lieu CH, et al
    Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
    Dis Colon Rectum. 2023;66:521-530.
    PubMed         Abstract available

  23. LUSSIEZ A, Rivard SJ, Hollingsworth K, Abdel-Misih SRZ, et al
    Management and Outcomes of Pathologic Upstaging of Clinical Stage I Rectal Cancers: An Exploratory Analysis.
    Dis Colon Rectum. 2023;66:543-548.
    PubMed         Abstract available

  24. CHURCH J
    Colorectal Adenomas Under Age 50.
    Dis Colon Rectum. 2023;66:e172.

  25. FU C, Zhou Z, Ji F
    3-Dimensional Laparoscopic Rectal Anterior Resection With Transanal Specimen Extraction For Rectal Prolapse.
    Dis Colon Rectum. 2023;66:e171.

  26. KONDO A, Kumamoto K, Asano E, Tsunemori H, et al
    Simple Identification of Diverting Ureters With Ileal Conduit Using Fluorescent Ureteral Catheter During Laparoscopic Rectal Cancer Surgery.
    Dis Colon Rectum. 2023;66:e169.

  27. OZGUR I, Lee GC, Gorgun E
    Management of Rectal Stricture After En-Bloc Endoscopic Submucosal Dissection for a Circumferential Lateral Spreading Tumor.
    Dis Colon Rectum. 2023;66:e168.

  28. WANG T, Tang Y, Pan W, Yan B, et al
    Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Stage IV Colorectal Cancer Patients After Surgery.
    Dis Colon Rectum. 2023 Mar 9. doi: 10.1097/DCR.0000000000002511.
    PubMed         Abstract available

  29. MAGUIRE LH, Mitchem JB, Smith JJ
    CREATEing Community for Colorectal Surgeon-Scientists.
    Dis Colon Rectum. 2023;66:491-492.

    Eur J Cancer

  30. DUCREUX M, Tabernero J, Grothey A, Arnold D, et al
    Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer.
    Eur J Cancer. 2023;184:137-150.
    PubMed         Abstract available

  31. ROSSINI D, Boccaccino A, Carullo M, Antoniotti C, et al
    Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials.
    Eur J Cancer. 2023;184:106-116.
    PubMed         Abstract available


  32. KUCUKKOSE E, Laoukili J, Gorelick AN, Degner S, et al
    Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer.
    Gastroenterology. 2023 Mar 9:S0016-5085(23)00256.
    PubMed         Abstract available

    Int J Cancer

  33. AHADOVA A, Witt J, Haupt S, Gallon R, et al
    Is HLA type a possible cancer risk modifier in Lynch syndrome?
    Int J Cancer. 2023;152:2024-2031.
    PubMed         Abstract available

    Int J Colorectal Dis

  34. DAVEY MG, O'Neill M, Regan M, Meshkat B, et al
    Impact of the 12-gene recurrence score in influencing adjuvant chemotherapy prescription in mismatch repair proficient stage II/III colonic carcinoma-a systematic review and meta-analysis.
    Int J Colorectal Dis. 2023;38:71.
    PubMed         Abstract available

  35. YI M, Wu Y, Li M, Zhang T, et al
    Effect of remote ischemic preconditioning on postoperative gastrointestinal function in patients undergoing laparoscopic colorectal cancer resection.
    Int J Colorectal Dis. 2023;38:68.
    PubMed         Abstract available

  36. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
    Adverse impact of tumor deposits in lymph node negative rectal cancer - a national cohort study.
    Int J Colorectal Dis. 2023;38:66.
    PubMed         Abstract available

  37. ORIVE M, Barrio I, Lazaro S, Gonzalez N, et al
    Five-year follow-up mortality prognostic index for colorectal patients.
    Int J Colorectal Dis. 2023;38:64.
    PubMed         Abstract available

    J Am Coll Surg

  38. MOAVEN O, Tavolara TE, Valenzuela CD, Cheung TT, et al
    Machine Learning Models for Predicting the Outcomes of Surgical Treatment of Colorectal Liver Metastases.
    J Am Coll Surg. 2023;236:884-893.
    PubMed         Abstract available

  39. CEPPA EP, Kim RC, Niedzwiecki D, Lowe ME, et al
    Closed Incision Negative Pressure Therapy to Reduce Surgical Site Infection in High-Risk Gastrointestinal Surgery: A Randomized Controlled Trial.
    J Am Coll Surg. 2023;236:698-708.
    PubMed         Abstract available

  40. MCKENNA NP, Bews KA, Behm KT, Habermann EB, et al
    Postoperative Venous Thromboembolism in Colon and Rectal Cancer: Do Tumor Location and Operation Matter?
    J Am Coll Surg. 2023;236:658-665.
    PubMed         Abstract available

  41. SHAH TA, Knapp L, Cohen ME, Brethauer SA, et al
    Truth of Colorectal Enhanced Recovery Programs: Process Measure Compliance in 151 Hospitals.
    J Am Coll Surg. 2023;236:543-550.
    PubMed         Abstract available

    J Surg Oncol

  42. SHAIKH CF, Woldesenbet S, Munir MM, Moazzam Z, et al
    Association between the environmental quality index and textbook outcomes among Medicare beneficiaries undergoing surgery for colorectal cancer (CRC).
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27229.
    PubMed         Abstract available

  43. MORGAN RB, Dhiman A, Sood D, Ong CT, et al
    Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
    J Surg Oncol. 2023;127:831-840.
    PubMed         Abstract available

  44. FLEMING AM, Deschner BW, Williard FW, Drake JA, et al
    Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
    J Surg Oncol. 2023;127:815-822.
    PubMed         Abstract available

  45. VAN KOOTEN RT, Ravensbergen CJ, van Buseck SCD, Grootjans W, et al
    Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
    J Surg Oncol. 2023;127:823-830.
    PubMed         Abstract available

  46. HANSDOTTER P, Scherman P, Nikberg M, Petersen SH, et al
    Treatment and survival of patients with metachronous colorectal lung metastases.
    J Surg Oncol. 2023;127:806-814.
    PubMed         Abstract available

  47. KERAMATI MR, Meshkati Yazd SM, Shahriarirad R, Ahmadi Tafti SM, et al
    Hand-sewn direct repair versus resection and hand-sewn anastomosis techniques for the reversal of diverting loop ileostomy after lower anterior rectal resection surgery: A randomized clinical trial.
    J Surg Oncol. 2023;127:798-805.
    PubMed         Abstract available


  48. ZHANG X, Ma D, Xuan B, Shi D, et al
    LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51.
    Oncogene. 2023 Mar 11. doi: 10.1038/s41388-023-02657.
    PubMed         Abstract available

    Oncol Rep

  49. WANG C, Xin H, Yan G, Liu Z, et al
    NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA.
    Oncol Rep. 2023;49:89.
    PubMed         Abstract available

    PLoS Comput Biol

  50. HAUGHEY MJ, Bassolas A, Sousa S, Baker AM, et al
    First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer.
    PLoS Comput Biol. 2023;19:e1010952.
    PubMed         Abstract available

    PLoS One

  51. YANG X, Cao Q, Ma B, Xia Y, et al
    Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition.
    PLoS One. 2023;18:e0277155.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.